Tandem Diabetes Care, Inc. , a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2023 and reaffirmed its financial guidance. | May 3, 2023
Acquisition Expands Addressable Market Opportunity and Complements Family of Insulin Delivery Offerings
Conference Call Tuesday, December 13, 2022 at 8:00am ET
. | December 13, 2022